{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"The Healthy Enterprise","title":"Diagnosing the Future: Biomarkers, AI, and the Fight Against Type 1 Diabetes with Eitan Akirav ","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/ad0f1cf6\"></iframe>","width":"100%","height":180,"duration":2798,"description":"In this episode, Eitan Akirav shares his journey from academia to the biotech industry, discussing the importance of mentorship, innovations in diabetes research, and the role of AI in healthcare. He emphasizes the need for a holistic approach to biomarkers and the future of oncology treatments. Eitan also provides insights into the challenges of consulting and the importance of building strong client relationships.\n\nChapters:\n00:00 Introduction to Eitan Akirav and His Journey\n03:13 Transitioning from Academia to Industry\n06:03 The Role of Mentorship in Career Development\n09:04 Leadership in Academia vs. Industry\n11:58 Innovations in Diabetes Research and Patents\n15:02 The Future of Diabetes Detection and Prevention\n17:56 The Impact of AI in Healthcare\n21:03 Disruptive Innovations in Life Sciences\n25:31 The Concept of Cure in Cancer Treatment\n28:09 Balancing Technology and Human Touch in Healthcare\n29:52 The Economic Challenges of Drug Development\n32:50 Advice for Newcomers in the Science Industry\n36:46 Challenges in Consulting and Marketing Yourself\n44:44 Final Thoughts and Reflections on the Journey\nGuest Information:\nGuest's Name: Eitan Akirav \nGuest's Title/Position: Founder & CEO\nGuest's Linkedin: https://www.linkedin.com/in/eitan-akirav/\nCompany/Affiliation: KonKai Ventures https://www.linkedin.com/company/konkai-consulting/posts/?feedView=all\nGuest's Bio: Eitan Akirav is a seasoned biotech leader with over 17 years of experience bridging scientific innovation and business strategy. From leading global biomarker programs at Cerba Research to launching rapid COVID-19 diagnostics at Enzo, he’s driven impactful solutions across the biotech and healthcare landscape. Earlier in his career at NYU, he secured multimillion-dollar research funding and led clinical trials in autoimmunity. With work featured in PNAS and Nature Immunology, Eitan continues to advance science at the intersection of research, innovation, and real-world application.\nTakeaways:\nEitan Akirav...","thumbnail_url":"https://img.transistorcdn.com/WKku9MQ84q-0q9Awqd5xdS4eoTolo1ocic6_1x8xlF0/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9mMjI4/MDliNWYyM2MxYWFi/NTkwZmIwNzJkYjk2/YjliMy5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}